Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: A prospective study

Inflammation Research

Volumn 61, Issue 8, 2012, Pages 845-852

  Stanisic, Milo ^a   Aasen, Ansgar Oddne ^b,d   Pripp, Are Hugo ^a   Lindegaard, Karl Fredrik ^a,d   Ramm Pettersen, Jon ^a   Lyngstadaas, Staale Petter ^c   Ivanovic, Jugoslav ^a   Konglund, Ane ^a   Ilstad, Eivind ^a   Sandell, Tiril ^a   Ellingsen, Omar ^a   Sæhle, Terje ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Chronic subdural hematoma; Interleukin 10; Interleukin 13; Interleukin 2R; Interleukin 5; Interleukin 6; Interleukin 7

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL ANALYSIS; SUBDURAL HEMATOMA;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; FEMALE; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84865153359     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0476-0     Document Type: Article

References (58)

1. Chen JC, Levy ML. Causes, epidemiology, and risk factors of chronic subdural hematoma. Neurosurg Clin North Am. 2000;11:399-406. (Pubitemid 30602968)
2. Weigel R, Schmiedek P, Krauss JK. Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry. 2003;74:937-43. (Pubitemid 36783000)
3. DE Haines, Harkey HL, al-Mefty O. The "subdural" space: a new look at an outdated concept. Neurosurgery. 1993;32:111-20. (Pubitemid 23020006)
4. Mack J, Squier W, Eastman JT. Anatomy and development of the meninges: implications for subdural collections and CSF circulation. Pediatr Radiol. 2009;39:200-10.
5. Reina MA, Casasola ODL, Lopez A, De Andres JA, Mora M, Fernandez A. The origin of the spinal subdural space: ultrastructure findings. Anesth Analg. 2002;94:991-5. (Pubitemid 34263753)
6. Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, Caroli E, Cantore G, Delfini R. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg. 2004;100:24-32. (Pubitemid 38017811)
7. Hirashima Y, Endo S, Kato R, Ohmori T, Nagahori T, Nishijima M, Karasawa K, Nojima S, Takaku A. Platelet-activating factor (PAF) and the development of chronic subdural haematoma. Acta Neurochir (Wien). 1994;129:20-5. (Pubitemid 24225615)
8. Hong HJ, Kim YJ, Yi HJ, Ko Y, Oh SJ, Kim JM. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol. 2009;71:161-6.
9. Suzuki M, Endo S, Inada K, Kudo A, Kitakami A, Kuroda K, Ogawa A. Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir (Wien). 1998;140:51-5. (Pubitemid 28052626)
10. Wada T, Kuroda K, Yoshida Y. Local elevation of the antiinflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma. Neurosurg Rev. 2006;29:242-5. (Pubitemid 44421192)
11. Hohenstein A, Erber R, Schilling L, Weigel R. Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma. 2005;22:518-28. (Pubitemid 40726980)
12. Katano H, Kamiya K, Mase M, Tanikawa M, Yamada K. Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence. J Neurosurg. 2006;104:79-84.
13. Nanko N, Tanikawa M, Mase M, Fujita M, Tateyama H, Miyati T, Yamada K. Involvement of hypoxia-inducible factor-1a and vascular endothelial growth factor in the mechanism of development of chronic subdural hematoma. Neurol Med Chir (Tokyo). 2009;49:379-85.
14. Shono T, Inamura T, Morioka T, Matsumoto K, Suzuki SO, Ikezaki K, Iwaki T, Fukui M. Vascular endothelial growth factor in chronic subdural haematomas. J Clin Neurosci. 2001;8:411-5. (Pubitemid 32843692)
15. Suzuki K, Takano S, Nose T, Doi M, Ohasi N. Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J Trauma. 1999;46:532-3. (Letter). (Pubitemid 29144362)
16. Vaquero J, Zurita M, Cincu R. Vascular endothelial growthpermeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wien). 2002;144:343-7. (Pubitemid 34507855)
17. Weigel R, Schilling L, Schmiedek P. Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien). 2001;143:811-9. (Pubitemid 32768591)
18. Friede RL, Schachenmayer W. The origin of subdural neomembranes II. Fine structure of neomembranes. Am J Pathol. 1978;92:69-84. (Pubitemid 8380709)
19. Moskala M, Gościński I, Kałuza J, Polar J, Krupa M, Adamek D, Pityński K, Miodoński AJ. Morphological aspects of the traumatic chronic subdural hematoma capsule: SEM studies. Microsc Microanal. 2007;13:211-9. (Pubitemid 46737858)
20. Yamashima T, Yamamoto S. The origin of inner membranes in chronic subdural hematomas. Acta Neuropathol. 1985;67: 219-25. (Pubitemid 15040830)
21. Fujisawa H, Ito H, Kashiwagi S, Nomura S, Toyosawa M. Kallikrein- kinin system in chronic subdural haematomas: Its role in vascular permeability and regulation of fibrinolysis and coagulation. J Neurol Neurosurg Psychiatry. 1995;59:388-94.
22. Murakami H, Hirose Y, Sagoh M, Shimizu K, Kojima M, Gotoh K, Mine Y, Hayashi T, Kawase T. Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of thrombomodulin in the mechanism. J Neurosurg. 2002;96:877-84. (Pubitemid 34415402)
23. Nomura S, Kashiwagi S, Fujisawa H, Ito H, Nakamura K. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot. J Neurosurg. 1994;81:910-3. (Pubitemid 24373472)
24. Suzuki M, Kudo A, Kitakami A, Doi M, Kubo N, Kuroda K, Ogawa A. Local hypercoagulative activity precedes hyperfibrinolytic activity in the subdural space during development of chronic subdural haematoma from subdural effusion. Acta Neurochir (Wien). 1998;140:261-6. (Pubitemid 28192896)
25. Weir B, Gordon P. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collection. J Neurosurg. 1983;58:242-5. (Pubitemid 13190259)
26. Kawano N, Suzuki K. Presence of smooth-muscle cells in the subdural neomembrane. J Neurosurg. 1981;54:646-51.
27. Sarkar C, Lakhtakia R, Gill SS, Sharma MC, Mahapatra AK, Mehta VS. Chronic subdural haematoma and the enigmatic eosinophil. Acta Neurochir (Wien). 2002;144:983-8. (Pubitemid 35232028)
28. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-8. (Pubitemid 30637822)
29. Li H, Lin X. Positive and negative signalling components involved in TNF-alpha-induced NF-kappaB activation. Cytokine. 2008;41:1-8. (Pubitemid 50012147)
30. Apte SH, Baz A, Kelso A, Kienzle N. Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8? T cells. Proc Natl Acad Sci USA. 2008;105:17475-80.
31. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783-836.
32. Boyman O, Ramsey C, Kim DM, Sprent J, Surh CD. Il-7/Anti-IL- 7 mAb complexes restore T cell development and induce homeostatic T cell expansion without lymphopenia. J Immunol. 2008;180:7265-75.
33. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood. 2002;99:3892-904. (Pubitemid 35332024)
34. Nelson BH, Lord JD, Greenberg PD. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature. 1994;369:333-6. (Pubitemid 24159546)
35. Schluns KS, Lefrançois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol. 2003;3:269-79. (Pubitemid 37328680)
36. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6:595-601. (Pubitemid 44134092)
37. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron A, Capron M. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulindependent secretion. J Exp Med. 1994;179:703-8. (Pubitemid 24058758)
38. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1-78. (Pubitemid 23289250)
39. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253-78. (Pubitemid 20135628)
40. Maruo N, Morita I, Shirao M, Murota S-I. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992;131:710-4.
41. Strazynski M, Eble JA, Kresse H, Schönherr E. Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation. J Biol Chem. 2004;279:21266-70. (Pubitemid 38656532)
42. Tilg H, Trehu E, Atkins MB. Interleukin-6 (IL-6) as an antiinflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994;83:113-8. (Pubitemid 24016522)
43. Trinchieri G. Interleukin-12 a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. J Immunol. 1995;13:251-76.
44. Numasaki M, Fukushi JI, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT. Interleukin-17 promotes angiogenesis and tumor growth. Blood. 2003;101:2620-7. (Pubitemid 36857622)
45. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang Y-H, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin. Nat Immunol. 2005;6:1133-41. (Pubitemid 41541791)
46. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol. 1998;16:27-55. (Pubitemid 28183358)
47. Moore KW, O'Gara A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol. 1993;11:165-90. (Pubitemid 23115005)
48. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440. (Pubitemid 26130190)
49. Moore KW, de Waal MR, Coffman RI, O'Gara A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683-765. (Pubitemid 32368050)
50. Seymour RM, Henderson B. Pro-inflammatory-anti-inflammatory cytokine dynamics mediated by cytokine-receptor dynamics in monocytes. IMA J Math Appl Med. 2001;18:159-92. (Pubitemid 32586175)
51. Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003; 21:425-56. (Pubitemid 37174537)
52. Minty A, Chalon P, Derocq JM, Dumont X, Guillemont JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Schire D, Ferrara P, Caput D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 1993;362:248-50. (Pubitemid 23093630)
53. Schlag G, Redl H. Mediators of injury and inflammation. World J Surg. 1996;20:406-10. (Pubitemid 26138586)
54. Stahel PF, Morganti-Kossmann MC, Kossmann T. The role of the complement system in traumatic brain injury. Brain Res Rev. 1998;27:243-56. (Pubitemid 28389310)
55. Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36:691-709. (Pubitemid 40732303)
56. Schmidt OI, Heyde CE, Ertel W, Stahel PF. Closed head injuryan inflammatory disease? Brain Res Rev. 2005;48:388-99. (Pubitemid 40585769)
57. Liew FY, McInnes IB. The role of innate mediators in inflammatory response. Mol Immunol. 2002;38:887-90. (Pubitemid 34496946)
58. McInnes IB, Gracie JA. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol. 2004;4:392-7. (Pubitemid 38987067)